News for Pro-Dex, Inc. (PDEX)

Shares of Pro-Dex Inc (PDEX) surged 3.13% in mid-day trading on Jun 17. The stock reached an intraday high of $42.05, before settling at $41.84, up from its

Shares of Pro-Dex Inc (PDEX) fell 3.19% in mid-day trading on Jun 4. The stock reached an intraday low of $41.10, before recovering slightly to $41.42, down

On May 27, 2025, analyst Edward Woo from Ascendiant Capital announced an update on Pro-Dex (PDEX), maintaining a "Buy" rating on the stock. The price target has

Pro-Dex’s Q3 gains in revenue, gross profit, and operating income show strength beyond YoY noise and crash-driven fear. Find out why PDEX stock is a strong buy.

ProDex (PDEX) delivered earnings and revenue surprises of 108.51% and 1.62%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Revenue: $17.4 million, slightly below the estimated $17.7 million, but up 22% year-over-year.EPS: $0.98 per diluted share, significantly surpassing the estima

Pro-Dex (PDEX) reports a 22% revenue increase in Q3 FY2025, reaching $17.4 million. Net income surged over 400% to $3.3 million, or $0.9

Pro-Dex (PDEX) Q3 highlights: GAAP EPS of $0.98, revenue up 21.8% Y/Y to $17.41M. Strong growth driven by new orthopedic product shipments.

ProDex (PDEX) delivered earnings and revenue surprises of 60.53% and 21.69%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Pro Dex Inc director Raymond Cabillot sells $409,925 in stock

Pro Dex director Raymond Cabillot sells shares worth $371,988

Investors can consider investing in PDEX right now as the stock has done extremely well through 2024 and its prospects continue to shine.

Meihua International (MHUA) experienced a significant stock movement, with its shares rising by 5.16%. The stock is currently priced at $0.379 per share, with a

Shares of Pro-Dex Inc (PDEX) fell 4.26% in mid-day trading on Nov 29. The stock reached an intraday low of $48.82, down from its previous close of $50.99. Thi

Pro-Dex stock soars to all-time high of $49.98 amid robust growth

Harvard Bioscience (HBIO) experienced a significant stock price increase of 5.56%, reaching $2.28 per share. The trading volume recorded was 120,363 shares with

Shares of Pro-Dex Inc (PDEX) surged 7.41% in mid-day trading on Nov 22. The stock reached an intraday high of $46.15, before settling at $45.47, up from its

Shares of Pro-Dex Inc (PDEX) surged 6.58% in mid-day trading on Nov 19. The stock reached an intraday high of $46.11, before settling at $44.72, up from its

The stock of Zhongjin Medical (ZJYL) experienced a significant drop of 5.60%. The price per share is now $2.36, with a trading volume of 74,314 shares and a tur